A university in Japan announced today that it didFirst induced pluripotent stem cell transplant (iPS) for the treatment of Parkinson's disease.
Transplantation, the first of its kind in the world to treat Parkinson's disease, was carried out last month by the University Hospital in Kyoto, today announced the educational center.
The recipient was a 50-year-old patient whose identity was not provided, which would be subject to periodic checks for two years to avoid rejection.
"We made the shaking on the left side of the patient's head and transplanted 2.4 million cells"Takayuki Kikuchi, surgeon at the University of Kyoto, told reporters assembled by the Kyodo local agency.
The cells used were created using iPS stem cells from donors who have a certain type of immunity that makes them less likely to reject transplants.
Parkinson's disease, which involves a chronic degeneration of neurons, still has no treatment. Only in Japan is estimated that there are 160,000 people with progressive neurological disorders.
On March 29, 2017, researchers at the Kobe General Medical Center in western Japan announced the first human IPS transplant surgery in a patient's retina.
The patient, affected by macular degeneration of the retina – an irregular ocular disorder that could cause blindness – received an injection of a retinal cell solution developed from other iPS from a donor.